BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wong VK, Cheong-Lee C, Ford JAE, Yoshida EM. Acute sensorineural hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment: Outcome after resumption of therapy. World J Gastroenterol 2005; 11(34): 5392-5393 [PMID: 16149154 DOI: 10.3748/wjg.v11.i34.5392]
URL: https://www.wjgnet.com/1007-9327/full/v11/i34/5392.htm
Number Citing Articles
1
Takuya Kitada, Takashi Narimatsu, Seiko Yamaguchi. Sudden hearing loss in a patient with chronic hepatitis C treated with pegylated interferon α2a and ribavirinKanzo 2009; 50(7): 371 doi: 10.2957/kanzo.50.371
2
Reham F. Zittoon, Yasser T. Madian, Diaa Eldeen M. Alhennawi, Hany S. Nadeem. Cochlear Changes Caused by Peginterferon α-2bJournal of Interferon & Cytokine Research 2018; 38(7): 311 doi: 10.1089/jir.2018.0012
3
Ana J. Pérez-Berná, Georg Pabst, Peter Laggner, José Villalaín. Biophysical characterization of the fusogenic region of HCV envelope glycoprotein E1Biochimica et Biophysica Acta (BBA) - Biomembranes 2009; 1788(10): 2183 doi: 10.1016/j.bbamem.2009.08.002
4
Rena Ellen Falk, Arti Pandya. Emery and Rimoin's Principles and Practice of Medical Genetics2013; : 1 doi: 10.1016/B978-0-12-383834-6.00150-6
5
Anna Piekarska, Magdalena Jozefowicz-Korczynska, Kamila Wojcik, Ewa Berkan. Sudden hearing loss in chronic hepatitis C patient suffering from Turner syndrome, treated with pegylated interferon and ribavirinInternational Journal of Audiology 2007; 46(7): 345 doi: 10.1080/14992020701261413
6
Marta Waliszewska-Prosół, Joanna Bladowska, Maria Ejma, Katarzyna Fleischer-Stępniewska, Weronika Rymer, Marek Sąsiadek, Tomasz Pawłowski, Krzysztof Małyszczak, Małgorzata Inglot, Agnieszka Żelwetro, Przemysław Podgórski, Brygida Knysz. Visual and brainstem auditory evoked potentials in HCV-infected patients before and after interferon-free therapy — A pilot studyInternational Journal of Infectious Diseases 2019; 80: 122 doi: 10.1016/j.ijid.2019.01.011
7
Mohamed Ibrahim Shabana, Ayman Rashad Amer, Abeir Osman Dabbous, Amani Ahmed Al-Sunni. Hearing profile in hepatitis C virus patients under dual treatment with interferon and ribavirinAudiological Medicine 2010; 8(3): 142 doi: 10.3109/1651386X.2010.515708
8
Ahmed Yacoob Mayet. Loss of Smell (Anosmia) and Taste (Ageusia) in a Patient Treated with Pegylated Interferon Alfa and RibavirinCurrent Therapeutic Research 2007; 68(4): 271 doi: 10.1016/j.curtheres.2007.08.006
9
M. Casale, C. Mazzarelli, U. Vespasiani Gentilucci, M. Potena, M. Pappacena, F. Faiella, G. Galati, F. Salvinelli, A. Picardi. Distortion-Product Otoacoustic Emissions: A Useful Test for Monitoring Ototoxicity Induced by Pegylated Interferon and Ribavirin Treatment in Patients with Chronic Hepatitis CInternational Journal of Immunopathology and Pharmacology 2012; 25(2): 551 doi: 10.1177/039463201202500229
10
Gulden Eser Karlidag, Turgut Karlidag, Kutbettin Demirdag, Erol Keles. The effects of pegylated interferon/lamivudine therapy on auditory functions in patients with chronic hepatitis BAuris Nasus Larynx 2011; 38(3): 312 doi: 10.1016/j.anl.2010.10.007
11
Christine Little, Maura K. Cosetti. A Narrative Review of Pharmacologic Treatments for COVID ‐19: Safety Considerations and Ototoxicity The Laryngoscope 2021; 131(7): 1626 doi: 10.1002/lary.29424
12
Vu Le, Ted Bader, Javid Fazili. A case of hearing loss associated with pegylated interferon and ribavirin treatment ameliorated by prednisoneNature Clinical Practice Gastroenterology & Hepatology 2009; 6(1): 57 doi: 10.1038/ncpgasthep1317
13
Savita Jain, Vandana Midha, Ajit Sood. Unilateral hearing loss due to pegylated interferon-α2b and ribavirin therapyIndian Journal of Gastroenterology 2011; 30(5): 239 doi: 10.1007/s12664-011-0126-4